Pharmacy Times November 19, 2024
Alana Hippensteele, Managing Editor

Key Takeaways

  • Outpatient care models reduce hospital stays, improving physical and psychological outcomes for transplant and cellular therapy patients.
  • Three outpatient models—total outpatient, outpatient/inpatient, and early discharge—require robust infrastructure and careful patient selection.
  • Studies show outpatient care is safe and effective for multiple myeloma and lymphoma, with reduced adverse events and improved survival rates.
  • Outpatient care improves social well-being but may shift financial burdens to patients and caregivers, necessitating support and equity strategies.
  • CAR T-cell therapy in outpatient settings faces challenges like cytokine release syndrome, requiring individualized care plans and robust management protocols.

Outpatient models are emerging as feasible alternatives to traditional inpatient care, offering potential benefits such as reduced hospitalization, improved social well-being, and cost savings.

The...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma / Biotech, Provider
3 RCM Strategies to Improve Denials Management
EHR Implementation Satisfaction Way Down, But a More Holistic Approach Can Help, KLAS Finds
Affordable Care Act Marketplace and Medicaid Expansion Enrollment Reached a Combined 44 Million in 2024
Medicare Accountable Care Organizations In 2023: Large Savings With Increasing Value-Based Programmatic Competition
Using AI And ML To Transform Care Delivery Processes

Share This Article